These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17224913)

  • 1. Overview of the pharmacogenomics of cigarette smoking.
    Ho MK; Tyndale RF
    Pharmacogenomics J; 2007 Apr; 7(2):81-98. PubMed ID: 17224913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The genetics of nicotine dependence: relationship to pancreatic cancer.
    MacLeod SL; Chowdhury P
    World J Gastroenterol; 2006 Dec; 12(46):7433-9. PubMed ID: 17167830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of the rate of nicotine metabolism and effects on smoking behavior.
    Johnstone E; Benowitz N; Cargill A; Jacob R; Hinks L; Day I; Murphy M; Walton R
    Clin Pharmacol Ther; 2006 Oct; 80(4):319-30. PubMed ID: 17015050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs and genotypes: how pharmacogenetic information could improve smoking cessation treatment.
    Lee AM; Tyndale RF
    J Psychopharmacol; 2006 Jul; 20(4 Suppl):7-14. PubMed ID: 16785264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence.
    Malaiyandi V; Sellers EM; Tyndale RF
    Clin Pharmacol Ther; 2005 Mar; 77(3):145-58. PubMed ID: 15735609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.
    Benowitz NL
    Clin Pharmacol Ther; 2008 Apr; 83(4):531-41. PubMed ID: 18305452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smoking behavior and related cancers: the role of CYP2A6 polymorphisms.
    Nakajima M
    Curr Opin Mol Ther; 2007 Dec; 9(6):538-44. PubMed ID: 18041664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between 5-hydroxytryptamine transporter gene-linked polymorphic region and smoking behavior in Chinese males.
    Chu SL; Xiao D; Wang C; Jing H
    Chin Med J (Engl); 2009 Jun; 122(12):1365-8. PubMed ID: 19567154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A meta-analytic review of the CYP2A6 genotype and smoking behavior.
    Carter B; Long T; Cinciripini P
    Nicotine Tob Res; 2004 Apr; 6(2):221-7. PubMed ID: 15203795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between genotype and retrospective ADHD symptoms predict lifetime smoking risk in a sample of young adults.
    McClernon FJ; Fuemmeler BF; Kollins SH; Kail ME; Ashley-Koch AE
    Nicotine Tob Res; 2008 Jan; 10(1):117-27. PubMed ID: 18188752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Heritability and candidate genes in tobacco use].
    Hamdani N; Ades J; Gorwood P
    Encephale; 2006; 32(6 Pt 1):966-75. PubMed ID: 17372541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP2B6 genotype alters abstinence rates in a bupropion smoking cessation trial.
    Lee AM; Jepson C; Hoffmann E; Epstein L; Hawk LW; Lerman C; Tyndale RF
    Biol Psychiatry; 2007 Sep; 62(6):635-41. PubMed ID: 17223085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYP2A6, MAOA, DBH, DRD4, and 5HT2A genotypes, smoking behaviour and cotinine levels in 1518 UK adolescents.
    Huang S; Cook DG; Hinks LJ; Chen XH; Ye S; Gilg JA; Jarvis MJ; Whincup PH; Day IN
    Pharmacogenet Genomics; 2005 Dec; 15(12):839-50. PubMed ID: 16272956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An association of CYP2A6 genotype and smoking topography.
    Strasser AA; Malaiyandi V; Hoffmann E; Tyndale RF; Lerman C
    Nicotine Tob Res; 2007 Apr; 9(4):511-8. PubMed ID: 17454707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP2A6 polymorphisms are associated with nicotine dependence and influence withdrawal symptoms in smoking cessation.
    Kubota T; Nakajima-Taniguchi C; Fukuda T; Funamoto M; Maeda M; Tange E; Ueki R; Kawashima K; Hara H; Fujio Y; Azuma J
    Pharmacogenomics J; 2006; 6(2):115-9. PubMed ID: 16402086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are serotonergic system genes associated to smoking cessation therapy success in addition to CYP2A6?
    Verde Z; Santiago C; Rodríguez González-Moro JM; de Lucas Ramos P; López Martín S; Bandrés F; Lucia A; Gómez-Gallego F
    Pharmacopsychiatry; 2014 Jan; 47(1):33-6. PubMed ID: 24127329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide association study of smoking behaviours in patients with COPD.
    Siedlinski M; Cho MH; Bakke P; Gulsvik A; Lomas DA; Anderson W; Kong X; Rennard SI; Beaty TH; Hokanson JE; Crapo JD; Silverman EK; ;
    Thorax; 2011 Oct; 66(10):894-902. PubMed ID: 21685187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variation of CYP2A6, smoking, and risk of cancer.
    London SJ; Idle JR; Daly AK; Coetzee GA
    Lancet; 1999 Mar; 353(9156):898-9. PubMed ID: 10093988
    [No Abstract]   [Full Text] [Related]  

  • 19. Genetic variability in CYP2A6 and the pharmacokinetics of nicotine.
    Mwenifumbo JC; Tyndale RF
    Pharmacogenomics; 2007 Oct; 8(10):1385-402. PubMed ID: 17979512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of CYP2A6 in the emergence of nicotine dependence in adolescents.
    Audrain-McGovern J; Al Koudsi N; Rodriguez D; Wileyto EP; Shields PG; Tyndale RF
    Pediatrics; 2007 Jan; 119(1):e264-74. PubMed ID: 17130279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.